Atrial Fibrillation
Showing NaN - NaN of 70
Atrial Fibrillation, Transient Ischemic Attack Trial in Germany (24-h Holter monitoring)
Recruiting
- Atrial Fibrillation
- Transient Ischemic Attack
- 24-h Holter monitoring
-
Aachen, Germany
- +6 more
Feb 19, 2020
Atrial Fibrillation, Thromboembolism, Stroke Trial in Worldwide (Subjects implanted with Amulet Device)
Completed
- Atrial Fibrillation
- +2 more
- Subjects implanted with Amulet Device
-
Murdoch, Western Australia, Australia
- +50 more
Dec 11, 2019
Atrial Fibrillation Trial in Worldwide (Edoxaban, VKA-Based Regimen)
Atrial Fibrillation, Stroke Trial in Worldwide (warfarin, Dabigatran dose 1, Dabigatran dose 2)
Stroke, Atrial Fibrillation, Embolism Trial in Worldwide (warfarin tablets, Edoxaban tablets (high dose regimen-60mg), Edoxaban
Completed
- Stroke
- +2 more
- warfarin tablets
- +4 more
-
Birmingham, Alabama
- +1015 more
Feb 8, 2019
DEtermining Accuracy and TrEnding CharacTerization of AF
Completed
- Atrial Fibrillation
- SJM Confirm ICM
-
Bad Neustadt, Germany
- +12 more
Feb 1, 2019
Atrial Fibrillation Trial in France, Germany, Greece (Holter monitoring)
Completed
- Atrial Fibrillation
- Holter monitoring
-
Créteil, France
- +13 more
Sep 17, 2018
Atrial Fibrillation, Percutaneous Coronary Intervention Trial in Worldwide (Dabigatran Etexilate 110mg, Warfarin 3mg, Aspirin)
Completed
- Atrial Fibrillation
- Percutaneous Coronary Intervention
- Dabigatran Etexilate 110mg
- +6 more
-
Birmingham, Alabama
- +420 more
Jul 27, 2018
HEart and BRain Interfaces in Acute Ischemic Stroke
Completed
- Stroke
- Atrial Fibrillation
-
Berlin, GermanyCharité, University Medicine Berlin
Jul 17, 2018
Atrial Fibrillation, Atrial Flutter Trial in Worldwide (warfarin, apixaban)
Completed
- Atrial Fibrillation
- Atrial Flutter
-
Birmingham, Alabama
- +1112 more
Jun 5, 2018
Atrial Fibrillation Trial in Worldwide (Apixaban, Acetylsalicylic acid)
Atrial Fibrillation Trial in Worldwide (Apixaban, Parenteral heparin and/or oral Vitamin K antagonist)
Completed
- Atrial Fibrillation
- Apixaban
- Parenteral heparin and/or oral Vitamin K antagonist
-
Birmingham, Alabama
- +164 more
May 21, 2018
Atrial Fibrillation Trial in Germany, United Kingdom (Implantation of LAA closure device)
Completed
- Atrial Fibrillation
- Implantation of LAA closure device
-
Berlin, Germany
- +6 more
Apr 3, 2018
Atrial Fibrillation Trial in Worldwide (Warfarin, Dabigatran Etexilate 150mg)
Completed
- Atrial Fibrillation
- Warfarin
- Dabigatran Etexilate 150mg
-
Little Rock, Arkansas
- +86 more
Jan 4, 2018
Atrial Fibrillation, Percutaneous Coronary Intervention Trial in Worldwide (rivaroxaban 2.5 mg, rivaroxaban 15 mg, rivaroxaban
Completed
- Atrial Fibrillation
- Percutaneous Coronary Intervention
- rivaroxaban 2.5 mg
- +7 more
-
Huntsville, Alabama
- +355 more
Aug 21, 2017
Atrial Fibrillation, Heart Failure Trial in Worldwide (Radiofrequency ablation, Conventional treatment)
Completed
- Atrial Fibrillation
- Heart Failure
- Radiofrequency ablation
- Conventional treatment
-
Adelaide, Australia
- +31 more
May 17, 2017
Atrial Fibrillation, Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation Trial in Worldwide (OPC-108459, Placebo)
Terminated
- Atrial Fibrillation
- +2 more
- OPC-108459
- Placebo
-
Washington, District of Columbia
- +24 more
Feb 24, 2017
Heart Failure (HF), Atrial Fibrillation Trial in Worldwide (Home Monitoring (Cardiac resynchronization therapy and atrial
Terminated
- Heart Failure (HF)
- Atrial Fibrillation
- Home Monitoring (Cardiac resynchronization therapy and atrial fibrillation therapy, with Home Monitoring feature)
- Home Monitoring (Cardiac resynchronization therapy and atrial fibrillation therapy, without Home Monitoring)
-
Antwerpen, Belgium
- +20 more
Feb 2, 2017
Atrial Fibrillation Trial in Worldwide (rivaroxaban, uninterrupted vitamin K antagonist (VKA))
Completed
- Atrial Fibrillation
- rivaroxaban
- uninterrupted vitamin K antagonist (VKA)
-
Beverly Hills, California
- +43 more
Jan 23, 2017
